Construction of scFv Gene and its Expression Vector
About 5 µg total RNA were extracted from approximately 10 6 hybridomas (C31B9) which can produce MAbs against PF and Alb and then reverse transcribed in a reaction volume of 33 µL using random hexamer primers according to the manufacturer's protocols (First-strand cDNA synthesis kit; Amersham Bioscience Corp., NJ, USA).
For the amplification of V H , primers and reaction buffer were supplied by the manufacturer (Amersham Bioscience Corp., NJ, USA). Since hybridoma C31B9 produced MAbs with a lambda light chain isotype, specific lambda primers were designed according to Krebber et al. [1] for the amplification of V L . A 50 µL PCR reaction mixture containing 6 µL first-strand cDNA, 0.2 µmol V L -reverse primer (5 -GCT GTT GTG ACT CAG GAA TC-3 ) and V L -forward primer (5 -ACC TAG GAC AGT CAG TTT GG-3 ), 250 µM of each dNTP, 4 mM MgCl 2, and 1 unit of TaKaRa Taq DNA polymerase was set up for amplification.
Amplified V H and V L fragments were purified by 1.5% (w/v) NuSieve GTG agarose gel electrophoresis and cloned into pGEM-T vectors (Promega Corp., WI, USA) for sequencing. A computer analysis of the cloned sequences was carried out using the SeqEd version 1.0.3 software (Applied Biosystems Inc., CA, USA) and the homology search and confirmation of V genes were performed using the IgBLAST of NCBI. Complementary determining regions (CDRs) were identified following the convention of Kabat et al. [2] . were loaded on a metal-chelate chromatography column pre-packed with His-Bind Resin (Novagen, EMD Biosciences Inc., Darmstadt, Germany). The target proteins were eluted using buffer A containing 500 mM imidazole. The eluate was collected and dialyzed against Buffer A to remove the imidazole, and then the protein concentration was adjusted to 225 g/mL in buffer A. The protein samples in denaturing conditions were re-natured (refolding) according to the methods of Tsumoto et al. [2] , [3] . Briefly, purified samples were reduced prior to refolding by incubation with 50 mM Tris-HCl (pH 8.0) containing 6 M GuHCl, 0.2 M NaCl and 10 mM -ME for at least 30 min at room temperature. After removing -ME by dialysis against the same buffer without -ME at 4 ºC, unfolded scFv was refolded by the gradual removal of GuHCl by means of stepwise dialysis from 6 to 0 M GuHCl through 3, 2, 1 and 0.5 M stages.
The oxidized forms of glutathione, GSSG (375 µM) and L-arginine (400 mM) were added at the 1 and 0.5 M stages.
Estimation of the dissociation constant (K D ) of refolded scFv in solution
First, a refolded scFv concentration for the antigen-antibody equilibrium experiment must be chosen, and then a suitable coated hapten-carrier protein (PF-HSA) concentration in the ELISA must be established for the measurement of the free antibody concentrations. Two 96-well immunoplates coated with PF-HSA (1 2 µg/mL in 50 mM carbonate buffer, pH 9.6) were prepared. Various concentrations of refolded scFv were added to one plate (Series 1) and then were incubated for 1 h at room temperature. The contents of each well in Series 1 were then removed and added to the corresponding wells of another plate (Series 2) and incubated for 1 h.
In the meantime, the Series 1 plate was washed TPBS three times, and then the scFv solution was combined with 100 µL 2,000-fold dilution anti-T7-Tag antibody HRP conjugates for 1 h.
After washing, 100 µL ABTS substrate solution was added to each well, and the plate was incubated for 15 min. The absorbance at 405 nm was measured using a microplate reader. Next, the washing, combining and substrate incubation steps were repeated for the Series 2 plate and the absorbance was measured as above. The absorbance readings for each series were then VL possessed the greatest similarity to mouse lambda 1 germline V region and was joined in the frame to the J lambda 1 segment. VH was closely related to the VhJ558 germline gene family and linked with DsP2 and JH4 segments in turn. The nucleotide sequences encoding the respective CDRs are underlined.
